PhilHealth Services

GLP-1 Agonists: What They Are, How They Work & Side Effects : Glucagon-like peptide-1 (GLP-1) receptor agonists have rapidly become some of the most widely discussed medications in the world. Originally developed to help manage Type 2 diabetes, these drugs have revolutionized obesity medicine and are now being prescribed to millions of people globally.

But with so much noise online, it can be difficult to separate medical facts from diet-culture fiction.

In this comprehensive guide, we will break down exactly what GLP-1 agonists are, the science behind how they work, and the side effects you need to know before starting treatment.

Quick Answer: What is a GLP-1 Agonist?

A GLP-1 agonist is a class of medications that mimics a naturally occurring hormone in the body called glucagon-like peptide-1. These medications are used to lower blood sugar in people with Type 2 diabetes and promote significant weight loss. They work by stimulating insulin production, slowing down digestion, and sending fullness signals to the brain.

What Are GLP-1 Agonists Used For?

Healthcare providers primarily prescribe GLP-1 therapies for three FDA-approved reasons:

1. Type 2 Diabetes Management

The original intent of GLP-1 medications was to improve glycemic control. They are highly effective at lowering A1C levels without causing dangerous drops in blood sugar (hypoglycemia), which is a common risk with older diabetes drugs like insulin or sulfonylureas.

2. Chronic Weight Management (Obesity)

Because they drastically reduce appetite, specific high-dose formulations of GLP-1s are FDA-approved for chronic weight management. They are prescribed to adults with a Body Mass Index (BMI) of 30 or higher, or a BMI of 27 or higher with a weight-related comorbidity (like high blood pressure).

3. Cardiovascular Risk Reduction

Extensive clinical trials have shown that certain GLP-1s significantly reduce the risk of major adverse cardiovascular events (like heart attacks and strokes) in adults with Type 2 diabetes or clinical obesity who have established cardiovascular disease.

How Do GLP-1 Medications Work? The 3 Core Mechanisms

When you eat a meal, your gut naturally releases the GLP-1 hormone to tell your body to process the incoming nutrients. However, natural GLP-1 only lasts in your system for a few minutes. GLP-1 medications are synthetically engineered to resist breaking down, meaning they stay active in your body for days or weeks.

They act on three primary organ systems:

1. The Pancreas (Insulin and Glucagon)

When your blood sugar rises, the medication binds to receptors in your pancreas. It triggers the beta cells to release insulin (which lowers blood sugar) and suppresses the alpha cells from releasing glucagon (a hormone that tells the liver to dump stored sugar into the blood).

2. The Stomach (Delayed Gastric Emptying)

GLP-1s physically slow down how fast food empties from your stomach into your small intestine. This delayed gastric emptying prevents sudden spikes in blood sugar after a meal and makes you feel physically full after eating very small portions.

3. The Brain (Appetite and Food Noise)

The medication crosses into the brain and targets the hypothalamus and reward centers. Not only does this suppress physical hunger, but it also quiets “food noise”—the obsessive, intrusive thoughts about eating that many people with obesity struggle with daily.

Popular GLP-1 Brand Names and Formulations

It is important to note that the same active ingredient is often sold under different brand names depending on what condition it is treating.

• Semaglutide: Sold as Ozempic (for diabetes), Wegovy (for weight loss), and Rybelsus (a daily oral pill for diabetes).
• Liraglutide: Sold as Victoza (for diabetes) and Saxenda (for weight loss). It is a daily injection.
• Dulaglutide: Sold as Trulicity (for diabetes).
• Tirzepatide: Sold as Mounjaro (for diabetes) and Zepbound (for weight loss). Note: Tirzepatide is technically a “dual-agonist” because it mimics both GLP-1 and another hormone called GIP, leading to even greater efficacy.

Common Side Effects of GLP-1 Agonists

Because these medications drastically alter digestion, gastrointestinal side effects are incredibly common, especially when first starting the medication or increasing the dose.

Most Common Mild Side Effects:

• Nausea and vomiting
• Diarrhea or constipation
• Heartburn (acid reflux)
• Fatigue
• Stomach pain

Systemic Side Effects to Watch For:

• Muscle Loss: Rapid weight loss on GLP-1s can result in a significant loss of lean muscle mass. Patients must prioritize protein intake and resistance training.
• “Ozempic Face”: A non-medical term for the facial aging and sagging that occurs when fat is rapidly lost from the face.

How to Manage Gastrointestinal Side Effects

If you are experiencing nausea while taking a GLP-1, you can mitigate it by making specific dietary adjustments:

1. Eat smaller, more frequent meals rather than three large meals.
2. Avoid high-fat and fried foods, as these take even longer to digest and will sit heavily in the stomach.
3. Stay hydrated, especially if experiencing diarrhea.
4. Stop eating as soon as you feel full; do not try to finish your plate.

Severe Risks and Who Should Avoid GLP-1s

While generally safe for the majority of the population, GLP-1 agonists carry a Black Box Warning and are contraindicated for certain individuals.

You should not take a GLP-1 if you have:

• A personal or family history of Medullary Thyroid Carcinoma (MTC).
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• A history of severe pancreatitis or gallbladder disease.
• Type 1 Diabetes (these drugs require a functioning pancreas that can produce insulin).
• Are pregnant, nursing, or planning to become pregnant.

Conclusion

GLP-1 agonists represent a massive leap forward in treating metabolic diseases. By simultaneously targeting the pancreas, stomach, and brain, they provide unmatched blood sugar control and weight loss results. However, they are powerful medications that require a commitment to managing side effects, adjusting dietary habits, and working closely with a healthcare provider to ensure long-term health and safety.

Comparison Table: Leading GLP-1 / GIP Medications

Active Ingredient	Brand Name (Diabetes)	Brand Name (Weight Loss)	Administration	Primary Mechanism
Semaglutide	Ozempic	Wegovy	Weekly Injection	GLP-1 Agonist
Semaglutide	Rybelsus	N/A	Daily Pill	GLP-1 Agonist
Tirzepatide	Mounjaro	Zepbound	Weekly Injection	Dual GIP/GLP-1 Agonist
Liraglutide	Victoza	Saxenda	Daily Injection	GLP-1 Agonist

Key Takeaways

• Multi-Organ Impact: GLP-1s work by stimulating insulin, slowing digestion, and suppressing appetite in the brain.
• Not Just for Weight Loss: They are crucial, life-saving medications for Type 2 diabetics and offer significant heart-health benefits.
• Gastrointestinal Side Effects: Nausea and constipation are the most common side effects due to the slowing of the digestive tract.
• Brand Names Vary: A drug’s brand name (e.g., Ozempic vs. Wegovy) dictates its FDA-approved use, even if the active ingredient is identical.

FAQ Section

1. Do GLP-1 agonists actually burn fat?

No, GLP-1s are not “fat burners.” They cause weight loss by dramatically reducing your appetite, which puts you in a severe caloric deficit. Your body then burns its stored fat for energy.

2. Why do you lose muscle on GLP-1 medications?

Any time you lose weight rapidly in a severe caloric deficit, your body breaks down both fat and lean muscle tissue. Patients must eat high-protein diets and lift weights to preserve muscle.

3. Can I drink alcohol while on a GLP-1?

While not explicitly forbidden, drinking alcohol on a GLP-1 can severely exacerbate nausea and increase the risk of low blood sugar (hypoglycemia).

4. What happens when you stop taking a GLP-1?

GLP-1 medications are designed for chronic use. If you stop taking them, the medication leaves your system, your appetite returns, and clinical trials show that most patients regain a significant portion of the weight they lost.

5. Are GLP-1s safe for long-term use?

Yes, they are approved for long-term, chronic management of obesity and Type 2 diabetes. However, long-term monitoring by a physician is required.

6. Does Medicare cover GLP-1 medications?

Medicare typically covers GLP-1s (like Ozempic) when prescribed for Type 2 diabetes. By law, Medicare does not currently cover medications prescribed strictly for weight loss (like Wegovy), though exceptions are being made if the patient has established heart disease.

7. How do I get a prescription for a GLP-1?

You must consult with a licensed healthcare provider, such as an endocrinologist, primary care physician, or a specialized telehealth weight-loss clinic.

8. Are Tirzepatide and Semaglutide the same thing?

No. Semaglutide (Ozempic/Wegovy) targets only the GLP-1 receptor. Tirzepatide (Mounjaro/Zepbound) targets both the GLP-1 and GIP receptors, often resulting in slightly higher average weight loss.